- ( +41 ) 78 834 6262
- info@tesct.org
- Rainweg 7,CH-3066 Berne-Stettlen.
- English
Healthcare systems and citizens across Europe and worldwide are facing unprecedented challenges driven by an ageing population, and increased prevalence of chronic diseases.Mental disorders have become Europe’s largest health challenge in the 21st century. The study (European College of Neuropsychopharmacology ECNP), 2011)also highlights that the majority of mental disorders remain untreated. Taken together with the large and increasing number of ‘disorders of the brain’, the true size and burden is even significantly higher.
There is a need to develop coordinated and strategic planning for health research and increase collaborative efforts across Europe to tackle the major health challenges facing Europe. Through better use of health data and measuring health outcomes, health policies can become more evidence-based, value- based and patient-centred.
Research shows that 550,000 people of working age die from Non-Communicable Diseases in the EU every year. Aside from the significant impact on individual patients, their families and carers, this causes a largely avoidable loss to the EU economy of €115 billion per year, corresponding to 0.8% of GDP. There is a need to develop coordinated and strategic planning for health research and increase collaborative efforts across Europe to tackle the major health challenges facing Europe
With better prevention, hundreds of thousands of lives can be saved every year in the EU and EU citizens can live their lives in good health. Prevention, including primary prevention, screening and vaccination, as well as investing in the prevention of chronic disease progression, will have the advantage of reducing both health- and socio- economic costs.
Dr. Mary Baker: “The sad thing is that pharma companies are not involved in the major health systems; they’re peripheral. They should not be seen as a cost, they should be seen as a trusted partner.“
Associate Membership of the Health Services Research Unit, University of Oxford Visiting Fellow within the London School of Economics (LSE) Health CentreConsultant to the World Health Organisation (WHO)
Through better use of health data and measuring health outcomes, health policies can become more evidence-based, value- based and patient-centred.
Off-label use, which is the practice of using a medicine outside its authorized indication, is often necessary in areas of unmet medical needs but poses challenges in terms of therapeutic innovation, patient safety and professional liability. There is currently no harmonized approach to off-label use across the EU (EBC, Annual Report 2017, Brussels).
Our healthcare systems are facing unprecedented challenges from an ageing population, and increased prevalence of chronic diseases driving rising demand on services. Currently, around 50 million EU citizens are estimated to suffer from two or more chronic conditions, and most of these people are over 65.
Public health policymakers, healthcare managers, providers and patients across Europe should be able to make decisions based on the best available evidence. Comparative outcomes data will help determine which medical practices, care pathways and providers have demonstrated the best results.
The TESCT Society is convinced that science, and the scientific method, are a clear example of fact-based collaborations to address global challenges. That refers to the goals of the Luca Coscioni Association, its members and supporters, to do their utmost to accompany the process preparing the “General Comment” on the “right to science” of the United Nations Committee on Economic, Social and Cultural Rights” also through the mobilization and coordination of stakeholders and civil society organizations, taking into account, among other things, the requests articulated in the appeal for the right to science launched by the Association in 2017 signed by, among others, Sir Richard J. Roberts, Nobel Laureate in Physiology or Medicine.
Copyright © 2019 TESCT. Developed by BayState InfoTech.
